GlassScriptPhysician profile
Jamie A Lipeles
NPI 1376794966
$5,141.17
in general payments reported to CMS, 2019-2025
17 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,427 · 2020: $679 · 2021: $385 · 2022: $236 · 2023: $154 · 2024: $147 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,030.59 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $796.71 | 2019-2025 | |
| Coloplast Corp | $286.61 | 2020-2021 | |
| Minerva Surgical, INC | $276.88 | 2019-2021 | |
| Abbvie INC. | $242.85 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $131.24 | 2019-2021 | |
| Myovant Sciences INC. | $66.16 | 2021-2022 | |
| Allergan, INC. | $57.88 | 2019-2020 | |
| Becton, Dickinson and Company | $49.51 | 2019 | |
| Amag Pharmaceuticals, INC. | $38.52 | 2019-2020 | |
| Organon LLC | $26.87 | 2025 | Nexplanon |
| Aspira Women'S Health INC | $25.36 | 2020 | |
| Boston Scientific Corporation | $25.08 | 2019 | |
| Kci USA, INC. | $24.64 | 2020 | |
| Galderma Laboratories, L.P. | $21.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20.49 | 2024 | Veozah |
| Coopersurgical, INC. | $20.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Lipeles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.